Cargando…
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis
Systemic sclerosis (SSc) is a clinically heterogeneous disorder of the connective tissue characterized by vascular alterations, immune/inflammatory manifestations, and organ fibrosis. SSc pathogenesis is complex and still poorly understood. Therefore, effective therapies are lacking and remain nonsp...
Autores principales: | Paolini, Chiara, Agarbati, Silvia, Benfaremo, Devis, Mozzicafreddo, Matteo, Svegliati, Silvia, Moroncini, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999630/ https://www.ncbi.nlm.nih.gov/pubmed/35409263 http://dx.doi.org/10.3390/ijms23073904 |
Ejemplares similares
-
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study
por: Mozzicafreddo, Matteo, et al.
Publicado: (2023) -
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine
por: Benfaremo, Devis, et al.
Publicado: (2023) -
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022) -
New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis
por: Gabrielli, Armando, et al.
Publicado: (2012) -
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis
por: Agarbati, S., et al.
Publicado: (2022)